Crystallization of free cholesterol in model macrophage foam cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 8, 1999, Pages 1891-1898

  Kellner Weibel, G ^a   Yancey, P G ^b   Jerome, W G ^b   Walser, T ^b   Mason, R P ^a   Phillips, M C ^a   Rothblat, G H ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Cholesterol crystals; Foam cells; Macrophages

Indexed keywords

8 (4 CHLOROPHENYLTHIO) CYCLIC AMP; ACETYL LOW DENSITY LIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN E; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE INHIBITOR; CHOLESTEROL ESTER; PROGESTERONE; SPHINGOSINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; FOAM CELL; HYDROLYSIS; LIPID BILAYER; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; X RAY DIFFRACTION;

EID: 0032800248     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.8.1891     Document Type: Article

References (39)

1. Small DM. Progression and regression of atherosclerotic lesions. Arteriosclerosis. 1988;8:103-129.
2. Ball RY, Stowers EC, Burton JH, Cary NRB, Skepper JN, Mitchinson MJ. Evidence that the death of macrophage foam cells contributes to the lipid core of atheroma. Atherosclerosis. 1995;114:45-54.
3. Felton CV, Cook D, Davies MJ, Oliver MF. Relation of plaque lipid composition and morphology to the stability of human aortic plaques. Arterioscler Thromb Vasc Biol. 1997;17:1337-1345.
4. Schroeder AP, Falk E. Vulnerable and dangerous coronary plaques. Atherosclerosis. 1995;118(suppl):S141-S149.
5. Stary HC. The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life. Eur Heart J. 1990;11:3-19.
6. Guyton JR, Klemp KF, Black BL, Bocan TMA. Extracellular lipid deposition in atherosclerosis. Eur Heart J. 1990;11:20-28.
7. Katz SS, Small DM. Isolation and partial characterization of the lipid phases of human atherosclerotic plaques. J Biol Chem. 1980;255: 9753-9759.
8. Guyton JR, Klemp KF. The lipid-rich core region of human atherosclerotic fibrous plaques. Am J Pathol. 1989;134:705-717.
9. Shio H, Haley NJ, Fowler S. Characterization of lipid-laden aortic cells from cholesterol-fed rabbits, III: intracellular localization of cholesterol and cholesteryl ester. Lab Invest. 1979;41:160-167.
10. Nolte CJM, Tercyak AM, Wu HM, Small DM. Chemical and physico-chemical comparison of advanced atherosclerotic lesions of similar size and cholesterol content in cholesterol-fed New Zealand White and Watanabe heritable hyperlipidemic rabbits. Lab Invest. 1990;62:213-222.
11. Kellner-Weibel G, Jerome WG, Small DM, Warner GJ, Stoltenborg JK, Kearney MA, Corjay MH, Phillips MC, Rothblat GH. Effects of intracellular free cholesterol accumulation on macrophage viability: a model for foam cell death. Arterioscler Thromb Vasc Biol. 1998;18:423-431.
12. Tangirala RK, Jerome WG, Jones NL, Small DM, Johnson WJ, Glick JM, Mahlberg FH, Rothblat GH. Formation of cholesterol monohydrate crystals in macrophage-derived foam cells. J Lipid Res. 1994;35:93-104.
13. Arbogast LY, Rothblat GH, Leslie MH, Cooper RA. Cellular cholesterol ester accumulation induced by free cholesterol-rich lipid dispersions. Proc Natl Acad Sic U S A. 1976;73:3680-3684.
14. Basu SK, Goldstein JL, Anderson RGW, Brown MS. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci U S A. 1976;73:3178-3182.
15. Gillotte KL, Davidson WS, Lund-Katz S, Rothblat GH, Phillips MC. Apolipoprotein A-I structural modification and functionality of reconstituted high density lipoprotein particles in cellular cholesterol efflux. J Biol Chem. 1996;271:23792-23798.
16. Warner GJ, Stoudt G, Bamberger M, Johnson WJ, Rothblat GH. Cell toxicity induced by inhibition of acyl coenzyme A cholesterol acyltransferase and accumulation of unesterified cholesterol. J Biol Chem. 1995; 270:5772-5778.
17. Kruth H. Localization of unesterified cholesterol in human atherosclerotic lesions. Am J Pathol. 1984;114:201-208.
18. 2+ and the phospholipid bilayer within isolated sarcoplasmic reticulum. Biophys J. 1985;20:245-272.
19. Mason RP, Trumbore MW, Pettegrew JW. Membrane interactions of a phosphomonoester elevated early in Alzheimer's disease. Neurobiol Aging. 1995;16:531-539.
20. Markwell MAK, Haas SM, Bieber LL, Tolbert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem. 1978;87:206-210.
21. Shirhatti V, Krishna G. A simple and sensitive method for monitoring drug-induced cell injury in cultured cells. Anal Biochem. 1985;147: 410-418.
22. Bernard DW, Rodriguez A, Rothblat GH, Glick JM. cAMP stimulates cholesteryl ester clearance to high density lipoproteins in J774 macrophages. J Biol Chem. 1991;266:710-716.
23. Craven BM. Crystal structure of cholesterol monohydrate. Nature. 1976; 260:727-729.
24. Brown MS, Ho YK, Goldstein JL. The cholesteryl ester cycle in macrophage foam cells. J Biol Chem. 1980;255:9344-9352.
25. Ridgway ND. Inhibition of acyl-CoA:cholesterol acyltransferase in Chinese hamster ovary (CHO) cells by short-chain ceramide and dihydroceramide. Biochim Biophys Acta. 1995;1256:39-46.
26. Loomis CR, Shipley GG, Small DM. The phase behavior of hydrated cholesterol. J Lipid Res. 1979;20:525-535.
27. Konikoff FM, Chung DS, Donovan JM, Small DM, Carey MC. Filamentous, helical, and tubular microstructures during cholesterol crystallization from bile. J Clin Invest. 1992;90:1155-1160.
28. Ruocco MJ, Shipley GG. Interaction of cholesterol with galactocerebroside and galactocerebroside-phosphatidylcholine bilayer membranes. Biophys J. 1984;46:695-707.
29. Tulenko TN, Chen M, Mason P. Physical effects of cholesterol on arterial smooth muscle membranes: evidence of immiscible cholesterol domains and alterations in bilayer width during atherogenesis. J Lipid Res. 1998; 39:947-956.
30. Bach D, Borochov N, Wachtel E. Phase separation of cholesterol in dimyristoyl phosphatidylserine cholesterol mixtures. Chem Phys Lipids. 1998;92:71-77.
31. Bernard DW, Rodriguez A, Rothblat GH, Glick JM. Influence of high density lipoprotein on esterified cholesterol stores in macrophages and hepatoma cells. Arteriosclerosis. 1990;10:135-144.
32. Smith JD, Miyata M, Ginsberg M, Grigaux C, Shmookler E, Plump AS. Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from a macrophage cell line to apolipoprotein acceptors. J Biol Chem. 1996;271:30647-30655.
33. Oram JF, Yokoyama S. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J Lipid Res. 1996;37:2473-2491.
34. Tabas I, Chen L-L, Clader JW, McPhail AT, Burnett DA, Bartner P, Das PR, Pramanik BN, Puar MS, Feinmark SJ, et al. Rabbit and human liver contain a novel pentacyclic triterpene ester with Acyl-CoA:cholesterol acyltransferase inhibitory activity. J Biol Chem. 1990;265:8042-8061.
35. Goldstein JL, Ho YK, Brown MS, Innerarity TL, Mahley RW. Cholesteryl ester accumulation in macrophages resulting from receptor mediated uptake and degradation of hypercholesterolemic canine β-very low density lipoproteins. J Biol Chem. 1980;255:1839-1848.
36. Vrettakou SS, Mitropoulos KA. On the mechanism of the modulation in vitro of acyl-CoA:cholesterol acyltransferase by progesterone. Biochem J. 1983;215:191-199.
37. Derby P, Nash EA, Neklason DW. Metherall JE. Role of multidrug resistance P-glycoproteins in cholesterol esterification. J Biol Chem. 1997;272:1026-1031.
38. Lange Y. Cholesterol movement from plasma membrane to rough endoplasmic reticulum. J Biol Chem. 1994;269:3411-3414.
39. Mazzone T, Krishna M, Lange Y. Progesterone blocks intracellular translocation of free cholesterol derived from cholesteryl ester in macrophages. J Lipid Res. 1995;36:544-551.